Association of HIV-1 viral phenotype in the MT-2 assay with perinatal HIV transmission

J Acquir Immune Defic Syndr. 2002 May 1;30(1):88-94. doi: 10.1097/00042560-200205010-00012.

Abstract

A case-control design study was used to investigate the association of maternal HIV-1 phenotype in MT-2 cells at or near the time of delivery with perinatal transmission of HIV-1, controlling for maternal CD4 percentage and duration of rupture of membranes, in 48 transmitting and 96 non-transmitting HIV-1-infected mothers who gave birth between 1990 and 1995. The non-syncytium-inducing (NSI) phenotype was more commonly seen in transmitting mothers compared with non-transmitting mothers (90% vs. 75%, p =.04). In a multivariable logistic regression model, the following maternal characteristics were significantly associated with HIV transmission: NSI phenotype (odds ratio [OR] = 6.08; 95% confidence interval [CI]: 1.73-21.35) and log(10) viral load (OR = 2.11; CI: 1.19-3.74). Finally, the association of NSI phenotype with transmission was stronger in transmitting women who received azidothymidine during pregnancy compared with transmitters who did not.

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Anti-HIV Agents / therapeutic use
  • Case-Control Studies
  • Cell Line
  • Female
  • Giant Cells / virology
  • HIV Infections / drug therapy
  • HIV Infections / transmission*
  • HIV Infections / virology
  • HIV-1 / genetics*
  • Humans
  • Infant
  • Infant, Newborn
  • Infectious Disease Transmission, Vertical*
  • Multivariate Analysis
  • Phenotype
  • Pregnancy
  • Pregnancy Complications, Infectious / drug therapy
  • Pregnancy Complications, Infectious / virology*
  • Regression Analysis
  • Zidovudine / therapeutic use

Substances

  • Anti-HIV Agents
  • Zidovudine